# LYNPARZA
> **NDA206162** · New Drug Application · Sponsor: ASTRAZENECA · Approved 2014-12-19
## Drug
- **FDA Application Number:** NDA206162
- **Application type:** New Drug Application
- **Brand name:** LYNPARZA
- **Generic name:** Olaparib
- **Active ingredients:** OLAPARIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ASTRAZENECA
- **First approval:** 2014-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206162)
---
*MORVS · CC0 1.0*